November 25, 2024 PRIMA Clinical Trial Data Safety Monitoring Board Votes to Recommend PRIMA Device for Submission for European Approval
November 23, 2024 Biohybrid neural interfaces: an old idea enabling a completely new space of possibilities
October 21, 2024 Science Announces Positive Preliminary Results For Vision Restoration In Pivotal Clinical Trial
October 3, 2024 Science Corp Announces New Suite of Neural Engineering Products to Accelerate Innovation and Reduce Complexity & Cost Industry Wide
About Us We are a clinical stage, vertically integrated technology company focused on solving some of neuroscience's hardest questions and most serious unmet medical needs. Get to know us
Technologies From advanced neural recording electronics to laser projection optics, we develop the full range of technologies needed for tomorrow's neural interfaces. Learn more
November 25, 2024 PRIMA Clinical Trial Data Safety Monitoring Board Votes to Recommend PRIMA Device for Submission for European Approval
November 23, 2024 Biohybrid neural interfaces: an old idea enabling a completely new space of possibilities
October 21, 2024 Science Announces Positive Preliminary Results For Vision Restoration In Pivotal Clinical Trial
October 3, 2024 Science Corp Announces New Suite of Neural Engineering Products to Accelerate Innovation and Reduce Complexity & Cost Industry Wide
August 7, 2024 Science Corporation Welcomes Tricia Gugler as Chief Financial Officer, Alex Feerst as Chief Legal Officer, and Joe Mornin as General Counsel